Computational analysis of data from a genome-wide screening identifies new PARP1 functional interactors as potential therapeutic targets.
Ontology highlight
ABSTRACT: Knowledge of interaction network between different proteins can be a useful tool in cancer therapy. To develop new therapeutic treatments, understanding how these proteins contribute to dysregulated cellular pathways is an important task. PARP1 inhibitors are drugs used in cancer therapy, in particular where DNA repair is defective. It is crucial to find new candidate interactors of PARP1 as new therapeutic targets in order to increase efficacy of PARP1 inhibitors and expand their clinical utility. By a yeast-based genome wide screening, we previously discovered 90 candidate deletion genes that suppress growth-inhibition phenotype conferred by PARP1 in yeast. Here, we performed an integrated and computational analysis to deeply study these genes. First, we identified which pathways these g
SUBMITTER: Lodovichi S
PROVIDER: S-EPMC6505629 | biostudies-literature | 2019 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA